Liver Life Walk has been a signature event of American Liver Foundation since 1999, said Lorraine Stiehl, Chief Executive Officer of ALF. Funds r ...

Gilead Sciences’ seladelpar has been granted conditional marketing authorisation by the European Commission (EC) to treat ...

Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years-old ...

Mirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with ...

Sian Ashcroft, a 35-year-old mother of three, died just 18 days after being diagnosed with terminal cholangiocarcinoma in January 2024. Despite initial misdiagnoses and being told she had months to ...

A young woman with three kids died within 18 days of being diagnosed with bile duct cancer, which the doctors initially ...

Chenodiol -- a naturally occurring human bile acid also known as chenodeoxycholic acid -- is the first FDA-approved drug indicated for the rare lipid storage disease and autosomal recessive genetic ...

The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

Mirum Pharmaceuticals' Ctexli wins FDA approval for CTX, a rare lipid storage disease. The company projects 2025 global sales of $420–$435 million.

Daniel Bisogno, who co-hosted Mexico's TV Azteca talk show 'Ventaneando,' died after complications from a September liver ...

Jim Mandich was dying, and he knew it. Bile duct cancer was taking his life, by degrees. It was aggressive, and the prognosis was grim.